BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3936717)

  • 1. Cross-over study of the pharmacokinetics of cefonicid administered intravenously or intramuscularly to healthy adult humans.
    Fourtillan JB; Leroy A; Lefebvre MA; Humbert G; Fillastre JP; Reumont G; Ramis N
    Eur J Drug Metab Pharmacokinet; 1985; 10(3):225-30. PubMed ID: 3936717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of cefonicid in uraemic patients.
    Fillastre JP; Fourtillan JB; Leroy A; Ramis N; Lefevre MA; Reumont G; Humbert G
    J Antimicrob Chemother; 1986 Aug; 18(2):203-11. PubMed ID: 3759731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of cefonicid, a new broad-spectrum cephalosporin.
    Barriere SL; Hatheway GJ; Gambertoglio JG; Lin ET; Conte JE
    Antimicrob Agents Chemother; 1982 Jun; 21(6):935-8. PubMed ID: 7114840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple-dose pharmacokinetics of cefonicid in patients with impaired renal function.
    Phelps RT; Conte JE
    Antimicrob Agents Chemother; 1986 May; 29(5):913-7. PubMed ID: 3729349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiological and pharmacokinetic evaluation of cefonicid, a long-acting cephalosporin.
    Mini E; Mazzei T; Periti P; Reali EF; Bordonaro P; Balocchini E; Ninu B
    Chemioterapia; 1987 Apr; 6(2):95-8. PubMed ID: 3594635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefonicid kinetics in subjects with normal and impaired renal function.
    Blair AD; Maxwell BM; Forland SC; Jacob L; Cutler RE
    Clin Pharmacol Ther; 1984 Jun; 35(6):798-803. PubMed ID: 6734031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of cefonicid in patients with skin and skin structure infections.
    Heim-Duthoy KL; Peltier GL; Guay DR; Matzke GR
    Antimicrob Agents Chemother; 1988 Apr; 32(4):485-7. PubMed ID: 3377460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetration of cefonicid in skin suction blister fluid in healthy volunteers.
    Cruciani M; Concia E; Passarella E; Soncini R
    Int J Clin Pharmacol Res; 1987; 7(3):225-7. PubMed ID: 3596863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics of cefamandole in rabbits].
    Klimova VS; Bobrov VI; Nazarova OI; Skala LZ; Iakovlev VP
    Antibiotiki; 1982 Dec; 27(12):34-8. PubMed ID: 7165292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration of cefonicid into human breast milk and various body fluids and tissues.
    Lou MA; Wu YH; Jacob LS; Pitkin DH
    Rev Infect Dis; 1984; 6 Suppl 4():S816-20. PubMed ID: 6522923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics and renal handling of cefonicid.
    Pitkin D; Dubb J; Actor P; Alexander F; Ehrlich S; Familiar R; Stote R
    Clin Pharmacol Ther; 1981 Nov; 30(5):587-93. PubMed ID: 7297018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of cefonicid in serum and its penetration into lung tissue, bronchial mucosa and pleura.
    Furlan G; Besa G; Broccali G; Gusmitta A
    Int J Clin Pharmacol Res; 1989; 9(1):49-53. PubMed ID: 2707925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefonicid concentrations in human aqueous humor.
    Axelrod JL; Kochman RS
    Arch Ophthalmol; 1984 Mar; 102(3):433-4. PubMed ID: 6608343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cefonicid in children.
    Furlanut M; D'Elia R; Riva E; Pasinelli F
    Eur J Clin Pharmacol; 1989; 36(1):79-82. PubMed ID: 2917594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of age and renal function on cefonicid pharmacokinetics.
    Trang JM; Monson TP; Ackerman BH; Underwood FL; Manning JT; Kearns GL
    Antimicrob Agents Chemother; 1989 Feb; 33(2):142-6. PubMed ID: 2719458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefonicid concentration in lung tissue after intramuscular administration.
    Cruciani M; Savio S; Concia E
    Int J Clin Pharmacol Res; 1987; 7(6):481-4. PubMed ID: 3440639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of pharmacokinetics.
    Cutler RE
    Rev Infect Dis; 1984; 6 Suppl 4():S803-8. PubMed ID: 6522921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue penetration and half-life of cefonicid.
    Nightingale CH; Quintiliani R; Dudley MN; Gough P; Hickingbotham M; Jordan NS; Rose D; Toscani M
    Rev Infect Dis; 1984; 6 Suppl 4():S821-8. PubMed ID: 6522924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic disposition of cefonicid in patients with renal failure and receiving hemodialysis.
    Barriere SL; Gambertoglio JG; Alexander DP; Stagg RJ; Conte JE
    Rev Infect Dis; 1984; 6 Suppl 4():S809-15. PubMed ID: 6522922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-performance liquid chromatographic determination of cefonicid in human plasma and urine.
    Brendel E; Zschunke M; Meineke I
    J Chromatogr; 1985 May; 339(2):359-65. PubMed ID: 4008574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.